brainstorm cell therapeutics
(BCLI:OTC BB)

Executive Profile*

Background*

Dr. Irit Arbel has been an Executive Vice President of Research and Development at Online Disruptive Technologies, Inc. since July 30, 2012. Dr. Arbel serves as National Sales Manager of Laboratoires Merck Sharp & Dohme-Chibret SNC. She is a Member of the RFB Investment House management team. Dr. Arbel has 15 years of management experience in the areas of cell therapy, medical devices, and pharmaceuticals. She was the co-founder and Chairperson of several medical device ... companies including Real Aesthetics Inc and BRH Medical. Dr. Arbel served as the President of Brainstorm Cell Therapeutics Inc. (Former Name: Golden Hand Resources Inc.) from April 28, 2004 to November 8, 2004 and served its Principal Executive Officer and Principal Accounting Officer until November 8, 2004. Dr. Arbel founded Brainstorm Cell Therapeutics Inc. She served as the President and Chief Executive Officer of Pluristem Therapeutics, Inc. (formerly AI Software Inc.) from May 30, 2003 to June 10, 2004. Following years of research in the fields of Alzheimer disease, immunology and osteoporosis with numerous publications, Dr. Arbel has a wealth of managerial experience through her position as Israeli Sales Manager of Merck, Sharp & Dohme Ltd. (MSD) from February 1998 to December 2002. From 1995 to 1997, Dr. Arbel served as the Head of research for Hadassa - Ein Karem Hospital in Jerusalem, Israel. Dr. Arbel specialized in the use of pharmaceuticals for neurology, ophthalmology and dermatology treatments. She has been a Director of Brainstorm Cell Therapeutics Inc. since May 2004, where she served as its Director since April 28, 2004. She served as a Director of Pluristem Therapeutics, Inc. from May 30, 2003 to June 10, 2004. She is a Member of the Neurological Association and American Society of Hematology. Dr. Arbel also holds a Chemical Engineering degree from the Technion, Israel Institute of Technology. Dr. Arbel received a Bachelor's Degree in Biology from Hebrew University in 1983 and a Masters and PHD in Medical Sciences from Technion University in 1988. Dr. Arbel earned her Post Doctorate degree in 1997 in Neurobiology from Hadassah Hospital Neurological Department. She has a Doctor of Science (D.Sc.) in Neurology from The Technion Medical School.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
BCLI:US	$0.21 USD	-0.005

COMPETITOR COMPENSATION